National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 77872 [2024-21739]
Download as PDF
<![CDATA[
77872
Federal Register / Vol. 89, No. 185 / Tuesday, September 24, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Form name
Type of respondent
Data Management and Sharing Plan ...................
VCOC Certification ...............................................
SBIR/STTR Funding Agreement Certification ......
Grant Applicant .............
Grant Applicant .............
Grant Applicant .............
Number of
responses per
respondent
73,117
6
1,500
Average
burden per
response
(in hours)
Total annual
burden hours
1
1
1
2
5/60
15/60
146,234
1
375
PHS Fellowship—Electronic
PHS Fellowship Supplemental Form (includes F
reference letters).
Biosketch (Fellowship) ..........................................
416–1 ....................................................................
PHS 416–5 ...........................................................
PHS 6031 .............................................................
Fellowship
cant.
Fellowship
cant.
Fellowship
cant.
Fellowship
cant.
Fellowship
cant.
Grant Appli-
6,707
1
13
87,191
Grant Appli-
6,707
1
2
13,414
Grant Appli-
29
1
10
290
Grant Appli-
6,707
1
5/60
559
Grant Appli-
6,217
1
5/60
518
239
1
11
2,629
486,749
486,749
........................
2,175,670
NIH Other Transaction
NIH Other Transaction Application Form .............
Total ...............................................................
Dated: September 16, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2024–21801 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Cystic Fibrosis
Research and Translation Centers.
Date: October 31–November 1, 2024.
Time: 9:30 a.m. to 6:00 p.m.
VerDate Sep<11>2014
18:07 Sep 23, 2024
Jkt 262001
Other Transaction Applicant.
.......................................
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, National Institute
of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, 6707
Democracy Boulevard, Rm 7015, Bethesda,
MD 20892–2542, 301–594–4721,
ryan.morris@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 18, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21739 Filed 9–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Post-Award
Reporting Requirements Including
Research Performance Progress
Report Collection (Office of the
Director)
AGENCY:
National Institutes of Health,
HHS.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Ms. Mikia P. Currie, Program
Analyst, Office of Policy for Extramural
Research Administration, 6705
Rockledge Drive, Suite 350, Bethesda,
Maryland 20892, or call a non-toll-free
number 301–435–0941 or email your
request, including your address to
ProjectClearanceBranch@mail.nih.gov.
Formal requests for additional plans and
SUMMARY:
E:\FR\FM\24SEN1.SGM
24SEN1
]]>Agencies
[Federal Register Volume 89, Number 185 (Tuesday, September 24, 2024)]
[Notices]
[Page 77872]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21739]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Cystic Fibrosis Research
and Translation Centers.
Date: October 31-November 1, 2024.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, NIDDK, Democracy II, Suite
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Ryan G. Morris, Ph.D., Scientific Review
Officer, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, 6707 Democracy Boulevard,
Rm 7015, Bethesda, MD 20892-2542, 301-594-4721, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: September 18, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-21739 Filed 9-23-24; 8:45 am]
BILLING CODE 4140-01-P
